MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study

Table 1

Clinical characteristics of patients with essential hypertension over the entire study (𝑛=234): basal, stage I = at 12 months.

	Basal (𝑛=234)	Stage I (𝑛=234)
Age (years)	60 ± 13	61 ± 13
Gender (% male)	54	54
BMI (kg/m^2)	30 ± 4	30 ± 4
SBP (mmHg)	149 ± 20	142 ± 11^b
DBP (mmHg)	87 ± 11	84 ± 11^b
PP (mmHg)	62 ± 18	58 ± 17^b
GFR (mL/min/1.73 m^2)	93 ± 39	95 ± 25
Total cholesterol (mg/dL)	212 ± 37	206 ± 33^a
Urea (mmol/L)	41 ± 11	42 ± 14
Sodium (mmol/L)	141 ± 4	141 ± 4
Potassium (mmol/L)	4.2 ± 0.4	4.3 ± 0.4
EF (%)	59 ± 5	59 ± 5
E/A ratio (m/s)	0.91 ± 0.25	0.94 ± 0.26
LVMI (g/m^2.7)	53 ± 17	53 ± 17

Results are shown as mean ± SD or percentage of subjects. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; GFR: glomerular filtration rate; EF: ejection fraction; E: maximal early mitral valve inflow; A: maximal late mitral valve inflow; LVMI: left ventricular mass index. ^a𝑃<0.05; ^b𝑃<0.01.